Abstract: The time-varying phase-switched screen (PSS) has demonstrated a significant potential for modulating radar target features, due to its exceptional capabilities in the harmonic generation and ...

Abstract: Triple-phase-shift (TPS) modulation endows dual-active-bridge (DAB) DC-DC converters with three independent degrees of freedom, enabling simultaneous control of power flow, device stress, ...

The Phase 1 clinical trial, STRIKE-001 (NCT07103018), is a multi-center, open-label dose escalation of KTX-2001 monotherapy (Part A) and in combination with darolutamide, an oral, nonsteroidal ...

Chowning is a composer, musician and professor that had a seismic impact on both the development of music technology and the ...

LCGC International salutes Jack Henion and Bob W.J. Pirok, winners of the 19th annual LCGC Lifetime Achievement and Emerging ...

Dewpoint Therapeutics, Inc., a clinical-stage biotechnology company pioneering condensate-modulating therapeutics, today announced that the first patient has been dosed in a Phase 1a/2a clinical trial ...

NMD Pharma is accelerating ignaseclant’s clinical development in CMT alongside multiple near-term clinical catalysts across its neuromuscular pipeline, with Phase 2 studies in spinal muscular atrophy ...

The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...

The FDA endorsed a ≥2-point reduction on a visual analogue scale for pain as a clinically meaningful endpoint for urcosimod in NCP. NCP is a chronic ocular pain syndrome with no FDA-approved therapies ...

Researchers have made a major advance in quantum computing with a new device that is nearly 100 times smaller than the diameter of a human hair. Published in the journal Nature Communications, the ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Brooklyn White Brooklyn White is a writer who has been playing Phase 10 for ...